Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05083338 · ClinicalTrials.gov registry record

Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy

A clinical trial of Malignant Solid Neoplasm and Colorectal Carcinoma, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
24
Enrollment target
1
Study location

NCT05083338 is a study of Malignant Solid Neoplasm and Colorectal Carcinoma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05083338, a study of Malignant Solid Neoplasm and Colorectal Carcinoma, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

This study learns if depression, anxiety, and catastrophizing (thought patterns that prompt people to expect the worst) are associated with chronic pain after surgery among patients who are scheduled to have cytoreductive surgery with intraoperative hyperthermic chemotherapy. Information from this study may improve the understanding of persistent and chronic postsurgical pain integrating multiple layers of biological and behavioral sciences.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Questionnaire Administration
  • PROCEDURE Pain Assessment

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-08-10
Est. Completion 2024-02-09

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05083338

The ClinicalTrials.gov registry entry for NCT05083338 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT05083338 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05083338 about?

NCT05083338 is a clinical study titled "Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy". This study learns if depression, anxiety, and catastrophizing (thought patterns that prompt people to expect the worst) are associated with chronic pain after surgery among patients who are scheduled to have cytoreductive surgery with intraoperative hyperthermic chemotherapy. Information from this s...

What is the current status of trial NCT05083338?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2021-08-10. Estimated completion is 2024-02-09.

What conditions does trial NCT05083338 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Colorectal Carcinoma, Gastric Carcinoma, Carcinomatosis, Appendix Carcinoma.

What interventions are being tested in trial NCT05083338?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Pain Assessment (PROCEDURE).

Who is sponsoring clinical trial NCT05083338?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05083338 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.